JP2016198046A - Biological substance extraction device, biological substance extractor, and biological substance extraction container - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a biological substance extraction device, a biological substance extractor, and a biological substance extraction container which make it possible to move a biological substance by applying magnetic force to a substance binding solid-phase carrier even in the case of connecting a plurality of containers to form a flow channel.SOLUTION: In a biological substance extraction device 6, an adsorption container 100 having a first flow channel 2a and a first cleaning container 210 having a second flow channel 2b are joined to form a flow channel 2 for moving a biological substance in a first direction D1, one end part of the first flow channel 2a is inserted into one end part of the second flow channel 2b to allow the first flow channel 2a and the second flow channel 2b to communicate with each other, and one end part of the first flow channel 2a has a first inner diameter changing part 123 in which an inner diameter of the first flow channel 2a gradually becomes smaller in a second direction D2.SELECTED DRAWING: Figure 11

Description

  The present invention relates to a biological material extraction device, a biological material extraction device, and a biological material extraction container.

  In the field of biochemistry, a technique of PCR (Polymerase Chain Reaction) has been established. Recently, the accuracy and detection sensitivity of amplification in the PCR method have improved, and it has become possible to amplify, detect, and analyze a very small amount of sample (DNA, etc.). PCR is a technique for amplifying a target nucleic acid by subjecting a solution (reaction solution) containing a nucleic acid (target nucleic acid) to be amplified and a reagent to thermal cycling. As a thermal cycle of PCR, a method of performing a thermal cycle at two or three stages of temperatures is common.

  On the other hand, the diagnosis of infectious diseases such as influenza in the medical field is currently mainly performed using a simple test kit such as immunochromatography. However, in such a simple test, the accuracy may be insufficient, and it is desired to apply PCR that can be expected to have a higher test accuracy to the diagnosis of infectious diseases.

  In recent years, as a device used for PCR, etc., nucleic acid is purified by alternately laminating an aqueous liquid layer and a water-insoluble gel layer in a capillary and passing magnetic particles to which the nucleic acid is attached. A device has been proposed (see Patent Document 1). However, when such a device is stored for a long period of time, the components of the aqueous liquid layer may gradually diffuse through the gel layer, and one aqueous liquid layer may be contaminated with the components of the other aqueous liquid layer.

International Publication No. 2012/086243

  The present invention relates to a bio-related substance extraction device and a bio-related substance that can move a substance-binding solid phase carrier by applying a magnetic force even when a plurality of containers are joined to form a flow path. An object of the present invention is to provide an extraction device and a biological material extraction container.

[Application Example 1]
The bio-related substance extraction device according to this application example is
A first container having a first flow path, and a second container having a second flow path,
One end of the first flow path is inserted into one end of the second flow path so that the first flow path and the second flow path communicate with each other, and the first container to the second container A flow path for moving the biological material in the first direction toward the
The one end of the first flow path has a first inner diameter changing portion in which the inner diameter of the first flow path gradually decreases in a second direction opposite to the first direction. Features.

According to the biological material extraction device according to this application example, even when one end of the first flow channel is inserted into one end of the second flow channel, It can move along the 1st inside diameter change part from the 2nd channel in the 2nd container to the 1st channel in the 1st container.

[Application Example 2]
The bio-related substance extraction device according to this application example is
A first container having a first flow path, and a second container having a second flow path,
One end of the first flow path is inserted into one end of the second flow path so that the first flow path and the second flow path communicate with each other, and the first container to the second container A flow path for moving the biological material in the first direction toward the
The one end portion of the first flow path is a finite value whose rate of change in inner diameter is not zero from the one end portion of the first flow path toward the second direction opposite to the first direction. It has the 1st internal diameter change part which has these.

  According to the biological material extraction device according to this application example, even when one end of the first flow channel is inserted into one end of the second flow channel, It can move along the 1st inside diameter change part from the 2nd channel in the 2nd container to the 1st channel in the 1st container.

[Application Example 3]
In the biological material extraction device according to this application example,
The one end portion of the second flow path may have a second inner diameter changing portion whose distance from the center of the second flow path gradually increases.

  According to the biological material extraction device according to this application example, the substance-binding solid phase carrier can be moved from the second channel to the end of the first channel along the inner surface of the second channel.

[Application Example 4]
In the biological material extraction device according to this application example,
In the first flow path, a first liquid and a fluid immiscible with the first liquid are sealed and stored,
In the second flow path, a second liquid and a fluid immiscible with the second liquid may be sealed and accommodated.

  According to the biological material extraction device according to this application example, it is possible to reliably prevent contamination between the first liquid and the second liquid until the first flow path and the second flow path communicate with each other.

[Application Example 5]
In the biological material extraction device according to this application example,
A substance-binding solid phase carrier can be disposed downstream of the first inner diameter changing portion where the biological substance moves.

  According to the bio-related substance extraction device according to this application example, the substance-binding solid phase carrier disposed on the downstream side of the first inner diameter changing section can be moved along the first inner diameter changing section.

[Application Example 6]
In the biological material extraction device according to this application example,
The first container is an adsorption container;
The second container is a cleaning container;
The first liquid is an adsorbent;
The second liquid may be a cleaning liquid.

  According to the biological material extraction device according to this application example, the substance-binding solid phase carrier can be moved from the cleaning container to the adsorption container along the first inner diameter changing portion after the flow path is formed.

[Application Example 7]
In the biological material extraction device according to this application example,
The second container is a first cleaning container;
A third container having a third flow path and containing a third liquid, a fluid immiscible with the third liquid, and a substance-binding solid phase carrier in the third flow path;
The second container and the third container are joined to form the flow path for moving the biological material in the first direction;
One end of the second flow path is inserted into one end of the third flow path, and the second flow path and the third flow path communicate with each other.
The one end portion of the second flow path may have a third inner diameter changing portion in which the inner diameter of the second flow path gradually decreases in the second direction.

  According to the biological substance extraction device according to this application example, the substance-binding solid phase carrier is moved from the third cleaning container to the second cleaning container along the third inner diameter changing portion after the flow path is formed. Can do.

[Application Example 8]
The bio-related substance extraction device according to this application example is
A fixing unit for fixing the biological material extraction device;
A magnet moving mechanism for moving a magnet along the biological material extraction device fixed to the fixing unit;
Have
The magnet moving mechanism moves the magnet to move the substance-binding solid phase carrier from the second container into the first container along the first inner diameter changing portion.

  According to the biological material extractor according to this application example, the substance-binding solid phase carrier is moved by moving the magnet along the first inner diameter changing portion by moving the magnet by the magnet moving mechanism. Can be moved from the second flow path to the first flow path.

[Application Example 9]
The bio-related substance extraction container according to this application example is
A first container having a first flow path;
One end of the first flow path is inserted into an end of the second flow path of the second container so that the first flow path and the second flow path communicate with each other. A flow path for moving the biological material in the first direction toward the two containers is formed,
The one end portion includes a first inner diameter changing portion in which the inner diameter of the first flow path gradually decreases in a second direction opposite to the first direction.

  According to the biological substance-extracting container according to this application example, the substance-binding solid-phase carrier can be used even when one end of the first channel is inserted into one end of the second channel. It can move along the 1st inside diameter change part from the 2nd channel in the 2nd container to the 1st channel in the 1st container.

It is a front view of the container assembly 1 which concerns on embodiment. It is a side view of the container assembly 1 which concerns on embodiment. It is a top view of container assembly 1 concerning an embodiment. It is a perspective view of container assembly 1 concerning an embodiment. It is AA sectional drawing in FIG. 3 of the container assembly 1 which concerns on embodiment. It is CC sectional drawing in FIG. 3 of the container assembly 1 which concerns on embodiment. It is a schematic diagram explaining operation of the container assembly 1 which concerns on embodiment. It is a schematic diagram explaining operation of the container assembly 1 which concerns on embodiment. 1 is a schematic configuration diagram of a PCR device 50. FIG. 2 is a block diagram of a PCR device 50. FIG. It is a longitudinal cross-sectional view of the nucleic acid extraction device 6 according to the embodiment. 4 is a longitudinal sectional view of a syringe unit 120, a first cleaning container 210, and a second cleaning container 220. FIG. It is a schematic diagram explaining operation of the nucleic acid extraction device 6 according to the embodiment. It is a schematic diagram explaining operation of the nucleic acid extraction device 6 according to the embodiment. It is a block diagram of 50 A of nucleic acid extraction apparatuses which concern on embodiment. It is a side view of 50 A of nucleic acid extraction apparatuses which concern on embodiment.

  Several embodiments of the present invention will be described below. The embodiments described below illustrate examples of the present invention. The present invention is not limited to the following embodiments, and includes various modified embodiments that are implemented within a range that does not change the gist of the present invention. Note that not all of the configurations described below are essential configurations of the present invention.

  The biological material extraction device according to the present embodiment includes a first container having a first flow path and a second container having a second flow path, and one end portion of the first flow path is the Inserted into one end of the second flow path, the first flow path and the second flow path communicate with each other, and the biological material is moved in the first direction from the first container toward the second container. The first end of the first channel has a first inner diameter that gradually decreases in a second direction opposite to the first direction. It has the inside diameter change part.

  Moreover, the biological material extraction device according to the present embodiment includes a first container having a first flow path and a second container having a second flow path, and one end of the first flow path. Is inserted into one end of the second flow path so that the first flow path and the second flow path communicate with each other, and the biological substance is introduced in the first direction from the first container toward the second container. A channel for movement is formed, and the one end portion of the first channel has an inner diameter from the one end portion of the first channel toward a second direction opposite to the first direction. It has the 1st internal diameter change part which has a finite value whose change rate of is not 0, It is characterized by the above-mentioned.

  Furthermore, the bio-related substance extraction container according to this application example includes a first container having a first flow path, and one end of the first flow path is an end of the second flow path of the second container. The first flow path and the second flow path are communicated with each other, and a flow path for moving a biological substance in a first direction from the first container toward the second container is formed, One end portion includes a first inner diameter changing portion in which the inner diameter of the first flow path gradually decreases in a second direction opposite to the first direction.

  Here, the biological substance is a substance related to the living body, such as nucleic acid (DNA, RNA), biological polymer such as polypeptide, protein, polysaccharide, protein, enzyme, peptide, nucleotide, amino acid, vitamin, etc. Including low molecular organic compounds derived from living organisms and inorganic compounds. In the following embodiments, a nucleic acid is used as a biological material for explanation.

The substance-binding solid phase carrier is a substance capable of holding a biological substance by adsorption, that is, by reversible physical bonding. The shape of the substance-binding solid phase carrier is preferably fine particles, but is not limited thereto, and may be fine fibers or nets, and is not particularly limited. The substance-bonding solid phase carrier preferably has magnetism in order to move it in a desired direction while adsorbing the biological substance. In the following embodiment, a description will be given using a magnetic bead 30 (see FIGS. 7 and 8 described later) that adsorbs a nucleic acid as a substance-binding solid phase carrier.

  The cleaning liquids 12, 14, and 16 (see FIGS. 7 and 8 to be described later) are liquids for cleaning the substance-binding solid phase carrier on which the biological substance is adsorbed. Therefore, by washing the substance-bound solid phase carrier with the washing liquid, it is possible to remove other impurities while adsorbing the biological substance adsorbed on the substance-bound solid phase carrier more stably.

  The fluid immiscible with the cleaning liquid is a fluid immiscible with the cleaning liquid in the cleaning container and can be phase-separated from the cleaning liquid. The fluid immiscible with the cleaning liquid is a substance inert to the cleaning liquid and includes a gas such as air. As the fluid that is immiscible with the cleaning liquid, when the cleaning liquid is an aqueous liquid, for example, oil or oil gel that is immiscible with the cleaning liquid can be used. The oil gel is obtained by gelling liquid oil with a gelling agent. In the present embodiment, the term “oil” simply excludes gelled ones. In the following embodiments, description will be given using oils 20, 22, 24, and 26 (see FIGS. 7 and 8 described later) as fluids that are immiscible with the cleaning liquid.

  The eluent 32 (see FIG. 7 and FIG. 8 described later) is one for detaching the biological substance from the substance-binding solid phase carrier and eluting it into the eluate. For example, water or a buffer solution can be used as the eluate.

  The fluid that is immiscible with the eluate is a fluid that is immiscible with the eluate in the elution container, and can be phase-separated from the eluate. A fluid that is immiscible with the eluate is a substance that is inert to the eluate. In the following embodiments, description will be given using oil 26 (see FIGS. 7 and 8 described later) as a fluid immiscible with the cleaning liquid.

1. Outline of Container Assembly First, an outline of the container assembly 1 according to the present embodiment will be described with reference to FIGS. FIG. 1 is a front view of a container assembly 1 (hereinafter sometimes referred to as a cartridge) according to an embodiment. FIG. 2 is a side view of the container assembly 1 according to the embodiment. FIG. 3 is a plan view of the container assembly 1 according to the embodiment. FIG. 4 is a perspective view of the container assembly 1 according to the embodiment. In addition, the state of the container assembly 1 in FIGS. 1 to 3 will be described as an upright state.

  The container assembly 1 includes an adsorption container 100, a cleaning container 200, an elution container 300, and a reaction container 400. The container assembly 1 is a container that forms a flow path (not shown) that communicates from the adsorption container 100 to the reaction container 400. The flow path of the container assembly 1 is closed at one end by the cap 110 and at the other end by the bottom 402.

  The container assembly 1 binds a nucleic acid to magnetic beads (not shown) in the adsorption container 100, purifies the magnetic beads while moving in the washing container 200, and extracts the nucleic acid in an eluate droplet (not shown) in the elution container 300. This is a container that performs pre-treatment for elution and thermal cycle processing of polymerase reaction for the droplet of eluate containing nucleic acid in the reaction container 400.

  Although the material of the container assembly 1 is not specifically limited, For example, glass, a polymer | macromolecule, a metal etc. can be used. It is more preferable to select a material having transparency in visible light such as glass or polymer as the material of the container assembly 1 because the inside (inside the cavity) can be observed from the outside of the container assembly 1. In addition, when a material that transmits magnetic force or a non-magnetic material is selected as the material of the container assembly 1, a magnetic force is applied from the outside of the container assembly 1 when a magnetic bead (not shown) is passed through the container assembly 1. Is preferred because it facilitates this. The material of the container assembly 1 can be, for example, polypropylene resin.

  The adsorption container 100 includes a cylindrical syringe part 120 that accommodates an adsorbing liquid (not shown), a plunger part 130 that is a movable pusher inserted into the syringe part 120, and one of the plunger parts 130. And a cap 110 that is fixed to the end of the head. The adsorption container 100 moves the cap 110 with respect to the syringe part 120 to slide the plunger part 130 on the inner surface of the syringe part 120, and pushes an unillustrated adsorbing liquid stored in the syringe part 120 to the cleaning container 200. be able to. The adsorbing liquid will be described later.

  The cleaning container 200 is obtained by joining and assembling the first to third cleaning containers 210, 220, and 230. The first to third cleaning containers 210, 220, and 230 each have one or more cleaning liquid layers partitioned by an oil layer (not shown). Then, by joining the first to third cleaning containers 210, 220, and 230, the cleaning container 200 has a plurality of cleaning liquid layers partitioned by a plurality of oil layers (not shown) inside. In the cleaning container 200 of the present embodiment, the example using the three cleaning containers including the first to third cleaning containers 210, 220, and 230 has been described. However, the present invention is not limited thereto, and the number may be appropriately increased or decreased according to the number of cleaning liquid layers. be able to. The cleaning liquid will be described later.

  The elution container 300 is joined to the third cleaning container 230 of the cleaning container 200 and accommodates the eluate therein so that the shape of the plug can be maintained. Here, the “plug” means a liquid when a specific liquid occupies one section in the flow path. More specifically, the plug of a specific liquid refers to a columnar shape in which only the specific liquid occupies the inside in the longitudinal direction of the flow path, and a certain space inside the flow path is formed by the liquid plug. Shows a state where is marked. The expression “substantially” here means that a small amount (for example, a thin film) of another substance (liquid or the like) may be present around the plug, that is, on the inner wall of the flow path. The eluate will be described later.

  The nucleic acid purification device 5 includes an adsorption container 100, a cleaning container 200, and an elution container 300.

  The reaction container 400 is a container that is joined to the elution container 300 and receives the liquid pushed out from the elution container 300, and is a container that stores droplets of the eluate containing the specimen during the thermal cycle process. Moreover, the reaction container 400 stores a reagent (not shown). The reagent will be described later.

2. Detailed Structure of Container Assembly Next, the detailed structure of the container assembly 1 will be described with reference to FIGS. FIG. 5 is a cross-sectional view taken along the line AA in FIG. 3 of the container assembly 1 according to the embodiment. FIG. 6 is a cross-sectional view taken along the line CC of FIG. 3 of the container assembly 1 according to the embodiment. Actually, the container assembly 1 is assembled in a state in which the contents such as the cleaning liquid are filled. However, in FIGS. 5 and 6, the contents are described to explain the structure of the container assembly 1. Is omitted.

2-1. Adsorption container In the adsorption container 100, the plunger part 130 is inserted from one opening end of the syringe part 120, and the cap 110 is inserted in the opening end of the plunger part 130. The cap 110 has a ventilation portion 112 at the center thereof, and the change in the internal pressure of the plunger portion 130 can be suppressed by the ventilation portion 112 when the plunger portion 130 is operated.

The plunger portion 130 is a substantially cylindrical pusher that slides on the inner peripheral surface of the syringe portion 120. The plunger portion 130 has an opening end portion into which the cap 110 is inserted and a bottom portion facing the opening end portion of the syringe portion 120. It has the rod-shaped part 132 extended in a longitudinal direction, and the front-end | tip part 134 of the front-end | tip of the rod-shaped part 132. The rod-shaped portion 132 protrudes from the center of the bottom portion of the plunger portion 130, and a through-hole is formed around the rod-shaped portion 132 so that the plunger portion 130 and the syringe portion 120 communicate with each other.

  The syringe part 120 constitutes a part of the flow path 2 of the container assembly 1, and includes a large diameter part that accommodates the plunger part 130, a small diameter part having an inner diameter smaller than the large diameter part, and a large diameter part to a small diameter part. A reduced diameter portion that reduces the inner diameter of the lip, a suction insertion portion 122 at the tip of the small diameter portion, and a cylindrical suction cover portion 126 that covers the periphery of the suction insertion portion 122. The large diameter portion, the small diameter portion, and the suction insertion portion 122 that are part of the flow path 2 of the container assembly 1 are substantially cylindrical.

  The tip part 134 of the plunger part 130 seals the small diameter part of the syringe part 120 and partitions the large diameter part, the reduced diameter part, and the small diameter part at the time of provision to the operator to form two compartments.

  The suction insertion part 122 of the syringe part 120 is inserted and fitted into the first receiving part 214 which is one open end part of the first cleaning container 210 in the cleaning container 200, so that the syringe part 120 and the first cleaning container are fitted. 210 is joined. The outer peripheral surface of the suction insertion portion 122 and the inner peripheral surface of the first receiving portion 214 are in close contact with each other to prevent the liquid as the contents from leaking to the outside.

2-2. Cleaning Container The cleaning container 200 is an assembly that forms part of the flow path 2 of the container assembly 1 and includes the first to third cleaning containers 210, 220, and 230. Since the basic structures of the first to third cleaning containers 210, 220, and 230 are the same, the structure of the first cleaning container 210 will be described, and the description of the second and third cleaning containers 220 and 230 will be omitted. To do.

  The first cleaning container 210 has a substantially cylindrical shape extending in the longitudinal direction of the container assembly 1, and includes a first insertion portion 212 formed at one opening end and a first opening formed at the other opening end. It has a receiving part 214 and a cylindrical first cover part 216 that covers the periphery of the first insertion part 212.

  The outer diameter of the first insertion part 212 is substantially the same as the inner diameter of the second receiving part 224. Further, the inner diameter of the first receiving portion 214 is substantially the same as the outer diameter of the suction insertion portion 122.

  By inserting and fitting the first insertion portion 212 of the first cleaning container 210 into the second receiving portion 224 of the second cleaning container 220, the outer periphery of the first insertion portion 212 is aligned with the inner periphery of the second receiving portion 224. The first cleaning container 210 and the second cleaning container 220 are joined together while closely sealing. Similarly, the first to third cleaning containers 210, 220, and 230 are connected to form the cleaning container 200. Here, “sealing” means sealing so that at least liquid or gas contained in a container or the like does not leak to the outside, including sealing that liquid or gas enters from the outside to the inside. Good.

2-3. The elution container The elution container 300 has a substantially cylindrical shape extending in the longitudinal direction of the container assembly 1 and constitutes a part of the flow path 2 of the container assembly 1. The elution container 300 has an elution insertion portion 302 formed at one opening end portion and an elution receiving portion 304 formed at the other opening end portion.

  The inner diameter of the elution receiving part 304 is substantially the same as the outer diameter of the third insertion part 232 of the third cleaning container 230. By inserting and fitting the third insertion portion 232 into the elution receiving portion 304, the outer periphery of the third insertion portion 232 is in close contact with the inner periphery of the elution receiving portion 304 and is sealed with the third cleaning container 230. The container 300 is joined.

2-4. Reaction container The reaction container 400 has a substantially cylindrical shape extending in the longitudinal direction of the container assembly 1 and constitutes a part of the flow path 2 of the container assembly 1. The reaction vessel 400 has a reaction receiving portion 404 formed at the open end.
And a bottom portion 402 formed at the other closed end portion, and a reservoir portion 406 that covers the reaction receiving portion 404.

  The inner diameter of the reaction receiving unit 404 is substantially the same as the outer diameter of the elution insertion unit 302 of the elution container 300. The elution container 300 and the reaction container 400 are joined by inserting and fitting the elution insertion part 302 into the reaction receiving part 404.

  A reservoir unit 406 having a predetermined space is provided around the reaction receiving unit 404. The reservoir unit 406 has a volume capable of receiving the liquid overflowing from the reaction vessel 400 due to the movement of the plunger unit 130.

3. Contents of Container Assembly and Operation of Container Assembly Next, the contents of the container assembly 1 will be described with reference to FIG. 7A, and the operation of the container assembly 1 will be described with reference to FIGS. explain. Drawing 7 is a mimetic diagram explaining operation of container assembly 1 concerning an embodiment. Drawing 8 is a mimetic diagram explaining operation of container assembly 1 concerning an embodiment. 7 and 8, each container is represented by a flow path 2 and the outer shape and the joining structure are omitted in order to explain the state of the contents.

3-1. Contents FIG. 7A shows the state of the contents in the flow path 2 in the state of FIG. The contents in the flow path 2 are, in order from the cap 110 toward the reaction vessel 400, the adsorbed liquid 10, the first oil 20, the first cleaning liquid 12, the second oil 22, the second cleaning liquid 14, the third oil 24, Magnetic beads 30, third oil 24, third cleaning liquid 16, fourth oil 26, eluent 32, fourth oil 26, and reagent 34.

  In the flow channel 2, portions having a large cross-sectional area (a thick portion of the flow channel 2) and small portions (a thin portion of the flow channel 2) are alternately arranged on a surface orthogonal to the longitudinal direction of the container assembly 1. Part or all of the first to fourth oils 20, 22, 24, 26 and the eluate 32 are accommodated in a narrow portion of the flow path 2. The cross-sectional area of the narrow part of the flow path 2 is maintained stably when the interface of adjacent liquids (which may be fluids; the same applies hereinafter) is disposed in the narrow part of the flow path 2. Has a possible area. Therefore, the liquid disposed in the narrow portion of the flow path 2 can stably maintain the positional relationship between the liquid and the other liquid disposed above and below the liquid. Even if the interface between the liquid disposed in the narrow portion of the flow path 2 and the other liquid disposed in the thick portion of the flow path 2 is formed in the thick portion of the flow path 2, Even if the interface is disturbed, the interface is stably formed at a predetermined position by placing the interface in a stationary state.

  The narrow portion of the flow path 2 is formed inside the adsorption insertion portion 122, the first insertion portion 212, the second insertion portion 222, the third insertion portion 232, and the elution insertion portion 302. In the elution container 300, the elution insertion portion 302 is formed. Extends upward beyond. In addition, the liquid accommodated in the thin part of the flow path 2 is stably maintained even before the container is assembled.

3-1-1. Oil The first to fourth oils 20, 22, 24, and 26 are all made of oil, and exist as plugs between liquids before and after each oil in the state of FIG. Since the first to fourth oils 20, 22, 24, and 26 exist as plugs, the liquids adjacent to each other before and after each oil are selected as liquids that are phase-separated from each other, that is, liquids that are not miscible. The oils constituting the first to fourth oils 20, 22, 24, 26 may be different types of oils. Examples of the oil that can be used for these include one selected from silicone oil such as dimethyl silicone oil, paraffin oil, mineral oil, and mixtures thereof.

3-1-2. Adsorbing liquid The adsorbing liquid 10 refers to a liquid that serves as a field for adsorbing nucleic acids to the magnetic beads 30 and is, for example, an aqueous solution containing a chaotropic substance. As the adsorbing liquid 10, for example, 5M guanidine thiocyanate, 2% Triton X-100, 50 mM Tris-HCl (pH 7.2) can be used. The adsorbing liquid 10 is not particularly limited as long as it contains a chaotropic substance, but the adsorbing liquid 10 may contain a surfactant for the purpose of disrupting the cell membrane or denaturing proteins contained in the cells. The surfactant is not particularly limited as long as it is generally used for nucleic acid extraction from cells or the like. Specifically, a Triton surfactant such as Triton-X or a tween surfactant such as Tween 20 is used. Nonionic surfactants such as ionic agents and anionic surfactants such as sodium N-uraroyl sarcosine (SDS) can be mentioned. It is preferable to use so that it may become a range. Furthermore, it is preferable to contain a reducing agent such as 2-mercaptoethanol or dithiothreitol. The lysis solution may be a buffer solution, but is preferably neutral at pH 6-8. Taking these into account, specifically, 3M-7M guanidine salt, 0% -5% nonionic surfactant, 0 mM-0.2 mM EDTA, 0M-0.2M reducing agent, etc. It is preferable to contain.

  Here, the chaotropic substance has a function of generating chaotropic ions (a monovalent anion having a large ionic radius) in an aqueous solution and increasing the water solubility of the hydrophobic molecule. If it contributes to adsorption | suction, it will not specifically limit. Specific examples include guanidine hydrochloride, sodium iodide, sodium perchlorate, and the like. Among these, guanidine thiocyanate or guanidine hydrochloride having a strong protein-modifying action is preferable. The specified concentration of these chaotropic substances varies depending on each substance. For example, when guanidine thiocyanate is used, it is within a range of 3M to 5.5M, and when guanidine hydrochloride is used, it is used at 5M or more. Is preferred.

  Since the chaotropic substance is present in the aqueous solution, the nucleic acid in the aqueous solution is thermodynamically advantageous when it is adsorbed to a solid rather than being surrounded by water molecules. Will be adsorbed.

3-1-3. Cleaning Liquid The first to third cleaning liquids 12, 14, and 16 are for cleaning the magnetic beads 30 to which the nucleic acid is bound.

  The first cleaning liquid 12 is a liquid that is phase-separated from both the first oil 20 and the second oil 22. The first washing liquid 12 is preferably water or a low salt concentration aqueous solution, and in the case of a low salt concentration aqueous solution, it is preferably a buffer solution. The salt concentration of the low salt concentration aqueous solution is preferably 100 mM or less, more preferably 50 mM or less, and most preferably 10 mM or less. Moreover, the 1st washing | cleaning liquid 12 may contain surfactant as mentioned above, and pH is not specifically limited. Although the salt for using the 1st washing | cleaning liquid 12 as a buffer solution is not specifically limited, Salts, such as a tris, hepes, pipes, and phosphoric acid, are preferable. Furthermore, the first washing solution 12 preferably contains alcohol in an amount that does not inhibit the adsorption of the nucleic acid to the carrier, the reverse transcription reaction, the PCR reaction, or the like. In this case, the alcohol concentration is not particularly limited.

  The first cleaning liquid 12 may contain a chaotropic substance. For example, when guanidine hydrochloride is contained in the first washing liquid 12, the magnetic beads 30 and the like can be washed while maintaining or enhancing the adsorption of the nucleic acid adsorbed to the magnetic beads 30 and the like.

The second cleaning liquid 14 is a liquid that is phase-separated from both the second oil 22 and the third oil 24. The second cleaning liquid 14 may basically have the same or different composition as the first cleaning liquid 12, but is preferably a solution that does not substantially contain a chaotropic substance. This is to eliminate the introduction of chaotropic substances into the later solution. As the 2nd washing | cleaning liquid 14, you may consist of 5 mM Tris hydrochloric acid buffer, for example. As described above, the second cleaning liquid 14 preferably contains alcohol.

  The third cleaning liquid 16 is a liquid that is phase-separated from both the third oil 24 and the fourth oil 26. The third cleaning liquid 16 may basically have the same or different composition as the second cleaning liquid 14, but does not contain alcohol. The third cleaning liquid 16 may include citric acid to prevent alcohol from being brought into the reaction vessel 400.

3-1-4. Magnetic Beads The magnetic beads 30 are beads that adsorb nucleic acids and preferably have relatively strong magnetism so that they can be moved by the magnet 3 outside the container assembly 1. The magnetic beads 30 may be, for example, silica beads or silica-coated beads. The magnetic beads 30 may be preferably silica-coated beads.

3-1-5. The eluate 32 is a liquid that is phase-separated from the fourth oil 26, and exists as a plug sandwiched between the fourth oils 26 and 26 in the flow path 2 in the elution container 300. The eluate 32 is a liquid for eluting the nucleic acid adsorbed on the magnetic beads 30 from the magnetic beads 30 into the eluate 32. Further, the eluate 32 becomes droplets in the fourth oil 26 by heating. For the eluent 32, for example, pure water can be used. Here, the “droplet” is a liquid surrounded by a free surface.

3-1-6. Reagent Reagent 34 contains components necessary for the reaction. When the reaction in the reaction vessel 400 is PCR, the reagent 34 is an enzyme such as a DNA polymerase for amplifying the target nucleic acid (DNA) eluted in the droplet 36 (see FIG. 8) of the eluate, and At least one of a primer (nucleic acid) and a fluorescent probe for detecting an amplification product can be included, and here, all of the primer, enzyme, and fluorescent probe are included. The reagent 34 is incompatible with the fourth oil 26 and dissolves and reacts when it comes into contact with the droplet 36 of the eluate 32 containing nucleic acid, and is the lowest part in the gravity direction of the flow path 2 in the reaction container 400. Exists in a solid state in the region. For example, the reagent 34 may be freeze-dried (freeze-dried).

3-2. Operation of Container Assembly An example of the operation of the container assembly 1 will be described with reference to FIGS.

The operation of the container assembly 1 is as follows:
(A) a step of assembling the container assembly 1 by joining the adsorption container 100, the cleaning container 200, the elution container 300, and the reaction container 400;
(B) introducing a sample containing nucleic acid into the adsorption container 100 in which the adsorbing liquid 10 is stored;
(C) a step of moving the magnetic beads 30 from the second cleaning container 220 to the adsorption container 100;
(D) swinging the adsorption container 100 to adsorb the nucleic acid to the magnetic beads 30;
(E) From the adsorption container 100, the first oil 20, the first cleaning liquid 12, the second oil 22, the second cleaning liquid 14, the third oil 24, the third cleaning liquid 16, and the fourth oil 26 are passed in this order, and the elution container Moving the magnetic beads 30 adsorbed with nucleic acids to 300;
(F) a step of eluting the nucleic acid from the magnetic beads 30 with respect to the eluate 32 in the elution container 300;
(G) contacting the droplet containing the nucleic acid with the reagent 34 in the reaction vessel 400;
including.

  Hereinafter, each process is demonstrated in order.

(A) Step of assembling container assembly 1 As shown in FIG. 7A, the step of assembling is a flow path that joins from the adsorption vessel 100 to the reaction vessel 400 and continues from the adsorption vessel 100 to the reaction vessel 400. Assemble container assembly 1 to form 2. In FIG. 7A, the cap 110 is attached to the adsorption container 100, but the cap 110 is attached to the plunger portion 130 after the step (B).

  More specifically, the elution insertion section 302 of the elution container 300 is inserted into the reaction receiving section 404 of the reaction container 400, and the third insertion section 232 of the third cleaning container 230 is inserted into the elution receiving section 304 of the elution container 300. The second insertion part 222 of the second cleaning container 220 is inserted into the third receiving part 234 of the third cleaning container 230, and the first insertion part of the first cleaning container 210 is inserted into the second receiving part 224 of the second cleaning container 220. 212 is inserted, and the suction insertion part 122 of the suction container 100 is inserted into the first receiving part 214 of the first cleaning container 210.

(B) Step of introducing the sample In the step of introducing, for example, a cotton swab to which the sample is attached is inserted into the adsorbing liquid 10 from the opening where the cap 110 of the adsorption container 100 is attached, and this is immersed in the adsorbing liquid 10. Do. More specifically, a cotton swab is inserted from an opening at one end of the plunger portion 130 in a state of being inserted into the syringe portion 120 of the adsorption container 100. Next, the cotton swab is taken out from the adsorption container 100 and the cap 110 is attached. This is the state shown in FIG. Further, the specimen may be introduced into the adsorption container 100 by a pipette or the like. In addition, if the specimen is in a paste form or a solid form, the specimen may be attached to or put into the inner wall of the plunger unit 130 with a scissors or tweezers, for example. As shown in FIG. 7A, the adsorbing liquid 10 is partially filled in the syringe part 120 and the plunger part 130, but a space is left on the opening side where the cap 110 is attached. .

  The sample contains the target nucleic acid. Hereinafter, this may be simply referred to as a target nucleic acid. The target nucleic acid is, for example, DNA or RNA (DNA: Deoxyribonucleic Acid and / or RNA: Ribonucleic Acid). The target nucleic acid is extracted from the specimen, eluted in an eluate 32 described later, and then used as a PCR template, for example. Examples of the specimen include blood, nasal mucus, oral mucosa, and other various biological samples.

(C) Step of moving the magnetic beads The step of moving the magnetic beads 30 is a magnet that is sandwiched between the third oils 24 and 24 of the second cleaning container 220 and exists in a plug shape as shown in FIG. The bead 30 is performed by moving the magnet 3 toward the adsorption container 100 in a state where the magnetic force of the magnet 3 arranged outside the container is applied.

  The cap 110 and the plunger part 130 are moved in the direction of extracting from the syringe part 120 in accordance with the movement of the magnetic beads 30 or earlier, and the sample in the adsorbed liquid 10 is moved from the plunger part 130 to the syringe part 120. Move in. Due to the movement of the plunger part 130, the flow path 2 that has been blocked by the tip part 134 communicates with the adsorbing liquid 10.

The magnetic beads 30 ascend in the flow path 2 as the magnet 3 moves, and reach the adsorbing liquid 10 with the specimen as shown in FIG.

(D) Step of adsorbing nucleic acid to magnetic beads The step of adsorbing nucleic acid is performed by swinging the adsorption container 100. This step can be efficiently performed because the opening of the adsorption container 100 is sealed by the cap 110 so that the adsorbed liquid 10 does not leak out. By this step, the target nucleic acid is adsorbed on the surface of the magnetic bead 30 by the action of the chaotropic agent. In this step, nucleic acids and proteins other than the target nucleic acid may be adsorbed on the surface of the magnetic beads 30.

  As a method of swinging the adsorption container 100, a known device such as a vortex shaker may be used, or shaking may be performed by an operator's hand. Further, the magnetism of the magnetic beads 30 may be used to swing the adsorption container 100 while applying a magnetic field from the outside.

(E) Step of moving magnetic beads adsorbed with nucleic acid The step of moving magnetic beads 30 adsorbed with nucleic acid moves while applying the magnetic force of the magnet 3 from the outside of the adsorption vessel 100, the washing vessel 200, and the elution vessel 300. As a result, the magnetic beads 30 are moved in the adsorbing liquid 10, the first to fourth oils 20, 22, 24, 26 and the first to third cleaning liquids 12, 14, 16.

  For example, a permanent magnet or an electromagnet can be used as the magnet 3. Moreover, the magnet 3 may be moved by an operator's hand or may be performed using a mechanical device or the like. Since the magnetic beads 30 have a property of being attracted by a magnetic force, the relative arrangement of the magnets 3 is changed to the adsorption vessel 100, the cleaning vessel 200, and the elution vessel 300 by using this property. The inside of the flow path 2 is moved. The speed at which the magnetic beads 30 pass through each cleaning liquid is not particularly limited, and the magnetic beads 30 may be moved so as to reciprocate along the longitudinal direction of the flow path 2 in the same cleaning liquid. In addition, when moving particles other than the magnetic bead 30 in a tube, this can be performed using gravity or a potential difference, for example.

(F) Step of Eluting Nucleic Acid In the step of eluting nucleic acid, the nucleic acid is eluted from the magnetic beads 30 in the elution liquid droplets 36 in the elution container 300. The eluate 32 in FIG. 7 was present as a plug in the narrow portion of the flow path of the elution container 300. However, the content liquid can be obtained by heating the reaction container 400 while moving the magnetic beads 30 as described above. It expands and moves upward in the elution container 300 as a droplet 36 as shown in FIG. Then, as shown in FIG. 8A, when the magnetic beads 30 reach the eluate droplets 36 in the elution container 300, the target nucleic acid adsorbed on the magnetic beads 30 is dissolved into the eluate by the action of the eluate. Elution into the liquid droplet 36.

(G) The process of making it contact with the reagent 34 The process of making it contact with the reagent 34 makes the droplet 36 containing a nucleic acid contact the reagent 34 in the lowest part in the reaction container 400. FIG. Specifically, as shown in FIG. 8B, the magnetic beads 30 to which the magnetic force of the magnet 3 is applied by pressing the cap 110 and pressing down the first oil 20 by the tip portion 134 of the plunger portion 130. Is maintained at a predetermined position, the droplet 36 of the eluate from which the target nucleic acid is eluted moves to the reaction vessel 400 and contacts the reagent 34 at the bottom of the reaction vessel 400. The reagent 34 in contact with the droplet 36 melts and mixes with the target nucleic acid in the eluate, and for example, PCR using thermal cycling can be performed.

4). PCR Device A PCR device 50 that performs nucleic acid elution processing and PCR using the container assembly 1 will be described with reference to FIGS. 9 and 10. FIG. 9 is a schematic configuration diagram of the PCR device 50. FIG. 10 is a block diagram of the PCR device 50.

  The PCR device 50 includes a rotation mechanism 60, a magnet moving mechanism 70, a pressing mechanism 80, a fluorescence measuring instrument 55, and a controller 90.

4-1. Rotation mechanism The rotation mechanism 60 includes a rotation motor 66 and a heater 65, and rotates the container assembly 1 and the heater 65 by driving the rotation motor 66. When the rotating mechanism 60 rotates the container assembly 1 and the heater 65 to turn upside down, the droplet containing the target nucleic acid moves in the flow path of the reaction container 400, and thermal cycle processing is performed.

  The heater 65 includes a plurality of heaters (not shown), and can include elution, high temperature, and low temperature heaters, for example. The elution heater heats the plug-like eluate of the container assembly 1 and promotes elution of the target nucleic acid from the magnetic beads to the eluate. The high temperature heater heats the liquid upstream of the flow path of the reaction vessel 400 to a temperature higher than that of the low temperature heater. The low temperature heater heats the bottom 402 of the flow path of the reaction vessel. A temperature gradient can be formed in the liquid in the flow path of the reaction vessel 400 by the high temperature heater and the low temperature heater. The heater 65 is provided with a temperature control device, and the liquid in the container assembly 1 can be set to a temperature suitable for processing in accordance with a command from the controller 90.

  The heater 65 has an opening through which the outer wall of the bottom 402 of the reaction vessel 400 is exposed. The fluorescence measuring device 55 measures the luminance of the droplet of the eluate from the opening.

4-2. Magnet moving mechanism The magnet moving mechanism 70 is a mechanism for moving the magnet 3. The magnet moving mechanism 70 draws the magnetic beads in the container assembly 1 toward the magnet 3 and moves the magnetic beads in the container assembly 1 by moving the magnet 3. The magnet moving mechanism 70 includes a pair of magnets 3, an elevating mechanism, and a swing mechanism.

  The swing mechanism is a mechanism that swings the pair of magnets 3 in the left-right direction in FIG. 9 (may be the front-rear direction in FIG. 9). The pair of magnets 3 is disposed so as to sandwich the container assembly 1 mounted on the PCR device 50 from the left and right directions (see FIGS. 7 and 8), and is perpendicular to the flow path of the container assembly 1 (here, The distance between the magnetic beads and the magnet 3 can be made closer in the left-right direction in FIG. Therefore, when the pair of magnets 3 are swung in the left-right direction as indicated by arrows, the magnetic beads in the container assembly 1 move in the left-right direction in accordance with the movement. The elevating mechanism can move the magnet 3 in the vertical direction and move the magnetic beads in the vertical direction in FIG. 9 in accordance with the movement of the magnet 3.

4-3. Pressing mechanism The pressing mechanism 80 is a mechanism that presses the plunger portion of the container assembly 1. When the plunger portion is pressed by the pressing mechanism 80, the droplet in the elution container 300 is pushed into the reaction container 400, PCR can be performed in the reaction vessel 400.

  In FIG. 9, the pressing mechanism 80 is shown arranged above the upright container assembly 1, but the direction in which the pressing mechanism 80 pushes the plunger portion is not the vertical direction in FIG. 9, for example, the vertical direction It may be inclined 45 degrees with respect to. By doing in this way, it becomes easy to arrange | position the press mechanism 80 in the position which does not interfere with the magnet moving mechanism 70. FIG.

4-4. Fluorescence measuring instrument The fluorescence measuring instrument 55 is a measuring instrument that measures the brightness of the droplets in the reaction vessel 400. The fluorescence measuring device 55 is disposed at a position facing the bottom portion 402 of the reaction vessel 400. Fluorescence measuring instrument 5
5 is desirable to be able to detect luminance in a plurality of wavelength regions so as to be compatible with multiplex PCR.

4-5. Controller The controller 90 is a control unit that controls the PCR apparatus 50. The controller 90 includes a processor such as a CPU and a storage device such as a ROM and a RAM. Various programs and data are stored in the storage device. Further, the storage device provides an area for developing a program. Various processes are realized by the processor executing the program stored in the storage device.

  For example, the controller 90 controls the rotation motor 66 to rotate the container assembly 1 to a predetermined rotation position. The rotation mechanism 60 is provided with a rotation position sensor (not shown), and the controller 90 drives and stops the rotation motor 66 according to the detection result of the rotation position sensor.

  Further, the controller 90 controls the heater 65 to turn on / off the heater to generate heat, thereby heating the liquid in the container assembly 1 to a predetermined temperature.

  Further, the controller 90 controls the magnet moving mechanism 70 to move the magnet 3 in the vertical direction, and swings the magnet 3 in the horizontal direction in FIG. 9 according to the detection result of a position sensor (not shown).

  In addition, the controller 90 controls the fluorescence measuring device 55 to measure the luminance of the droplet in the reaction container 400. This measurement result is stored in a storage device (not shown) of the controller 90.

  The container assembly 1 is attached to the PCR device 50, and the above steps 3-2 (C) to (G) can be performed, and further PCR can be performed.

  As described above, in the biological substance extraction device, the elution container 300 may be connected to the washing container 200 as in the nucleic acid purification device 5, and the nucleic acid purification device 5 is further in the reaction container as in the container assembly 1. 400 may be connected.

5. Nucleic Acid Extraction Device The nucleic acid extraction device 6 will be described in detail as a biological material extraction device with reference to FIGS. FIG. 11 is a longitudinal sectional view of the nucleic acid extraction device 6 according to the embodiment. Since the basic configuration of the nucleic acid extraction device 6 is the same as that of the adsorption container 100 and the cleaning container 200 of the container assembly 1, common portions are denoted by common reference numerals, and redundant description is omitted.

  As shown in FIG. 11, in the nucleic acid extraction device 6, the adsorption container 100 as the first container, the first cleaning container 210 as the second container, and the second cleaning container 220 as the third container are joined. Thus, the flow path 2 for moving the target nucleic acid which is a biological substance is formed. As shown in FIGS. 7 and 8, the flow path 2 has thick portions and thin portions alternately arranged. FIG. 11 shows cross-sections S1 to S4 in which the cross-sectional area of each part of the flow path 2 is doubled in order to explain the difference in cross-sectional area of the flow path 2 of each part.

  In FIG. 11, the fluid housed in the nucleic acid extraction device 6 is omitted for the explanation of the flow path 2, but is not substantially different from the arrangement of the fluid in each container in FIG. 12 described later. In addition, in FIG. 11, since it is difficult to describe the arrow of the 1st direction D1 and the 2nd direction D2 in the flow path 2, it has shown in the side of the nucleic acid extraction device 6 for convenience.

  In the nucleic acid extraction device 6, one end of the first flow path 2a is inserted into one end of the second flow path 2b, and the adsorption container 100 and the first washing container 210 are joined, and the first flow path 2a. And the second channel 2b communicate with each other, and the channel 2 for moving the target nucleic acid in the first direction D1 from the adsorption container 100 toward the first washing container 210 is formed. Also, one end of the second flow path 2b is inserted into one end of the third flow path 2c so that the first cleaning container 210 and the second cleaning container 220 are joined, and the second flow path 2b and the second flow path 2b The three flow paths 2c communicate with each other to form the flow path 2 for moving the target nucleic acid in the first direction D1 from the first washing container 210 toward the second washing container 220. The number of cleaning containers can be set as appropriate according to the application, and the third cleaning container 230, elution container 300, and reaction container 400 can be appropriately selected and joined as in the container assembly 1. The 1st-3rd flow paths 2a-2c are flow path formation parts for forming flow path 2 by joining containers, and the portion which does not constitute flow path 2 in the state where containers were joined Including.

  The adsorption container 100 has an adsorption insertion part 122 at one end of the first flow path 2a, and the first cleaning container 210 has a first receiving part 214 at one end of the second flow path 2b. The first flow path 2a and the second flow path 2b communicate with each other with the suction insertion section 122 inserted into the first receiving section 214.

  One end 120d (FIGS. 13 and 14) of the first flow path 2a has a first inner diameter that the inner diameter of the first flow path 2a gradually decreases in the second direction D2 opposite to the first direction D1. It has a change part 123. By having the first inner diameter changing portion 123, even if one end of the first channel 2a is inserted into one end of the second channel 2b, the substance-binding solid phase carrier is used. A certain magnetic bead 30 (FIGS. 12 to 14) may be moved along the first inner diameter changing portion 123 from the second flow path 2 b in the first cleaning container 210 to the first flow path 2 a in the adsorption container 100. it can.

  The first inner diameter changing portion 123 has a finite value in which the change rate of the inner diameter is not zero from the opening 120d (FIGS. 13 and 14) of the first flow path 2a toward the second direction D2. The change rate of the inner diameter is the ratio of the change in the diameter of the inner surface of the flow path 2 with respect to the change in the unit length from the end 120d in the second direction D2. If the change rate of the inner diameter is not zero, it changes, and if the change rate of the inner diameter has a finite value, there is no portion like a step that is orthogonal.

  Thus, the first inner diameter changing portion 123 is an annular surface for smoothly transitioning to the thick part (cross section S4) of the second flow path 2b wider than the narrow part (cross section S2) of the first flow path 2a. There is no abrupt change in the second direction D2, for example, a surface extending in a direction orthogonal to the second direction D2. This is because the movement of the magnetic beads 30 moving along the surface forming the flow path 2 is not hindered. The first inner diameter changing portion 123 has a truncated cone shape because the cross section of the flow channel 2 is circular, but is not limited to this, and the inner surface shape of the first and second flow channels 2a and 2b to be connected is the same. It can be set as appropriate.

  One end of the second flow path 2b of the first cleaning container 210 has a third inner diameter changing portion 213a in which the inner diameter of the second flow path 2b gradually decreases toward the second direction D2. By having the third inner diameter changing portion 213a, the magnetic beads 30 can be moved from the second cleaning container 220 to the first cleaning container 210 along the third inner diameter changing portion 213a after the flow path 2 is formed. it can. Note that the third inner diameter changing portion 213a has the same configuration as the first inner diameter changing portion 123, and thus description thereof is omitted.

In the nucleic acid extraction device 6, the magnetic beads 30 are arranged on the downstream side where the target nucleic acid moves from the first inner diameter changing section 123 and the third inner diameter changing section 213a. By providing the first inner diameter changing portion 123 and the third inner diameter changing portion 213a, the magnetic beads 30 arranged on the downstream side are transferred to the third flow path by the first inner diameter changing portion 123 and the third inner diameter changing portion 213a. It can move from 2c to the first flow path 2a. In addition, the moving direction (first direction D1) of the target nucleic acid, which is a biological substance, is the direction from the first flow path 2a to the second flow path 2c, and the moving direction of the magnetic beads 30 (second direction D2) is , The reverse direction of the first direction D1.

  When the magnetic beads 30 are stored for a long time together with the chaotropic substance, the function of adsorbing the target nucleic acid is lowered. Usually, the adsorbing liquid 10 contains a chaotropic substance, and even if the adsorbing liquid 10 is held in a plug shape by the first oil 20, the movement of the chaotropic substance at the molecular level cannot be completely prevented. Therefore, it is desirable to store the magnetic beads 30 in a container different from the adsorption container 100 in which the adsorption solution 10 is sealed and stored until immediately before the nucleic acid extraction step. Since the magnetic beads 30 are fine particles as described above, introduction into the adsorption container 100 manually reduces the work efficiency. Therefore, the workability can be improved by using the one previously held in the second washing container 220 like the nucleic acid extraction device 6. Further, the cleaning liquid may contain a slight amount of chaotropic substance. In that case, as in the nucleic acid extraction device 6, a second cleaning container 220 different from the first cleaning container 210 containing the first cleaning liquid 12 containing the chaotropic substance is prepared, and the magnetic beads 30 are placed in the second cleaning container 220. It is desirable to keep it inside. The second cleaning liquid 14 in the second cleaning container 220 does not contain a chaotropic substance.

  Then, as described in the container assembly 1 and as described later, the adsorbing container 100 in which each liquid is sealed and housed, the first cleaning container 210 and the second cleaning container 220 are joined to form the flow path 2. Therefore, it is possible to prevent the magnetic beads 30 from being deteriorated by the chaotropic substance.

  In this way, by storing the magnetic beads 30 in the second cleaning container 220 different from the adsorption container 100, the magnetic beads having a minute step formed at the joining portion between the adsorption container 100 and the second cleaning container 220. This hinders the movement of 30. The first inner diameter changing portion 123 and the third inner diameter changing portion 213a solve the problem of movement of the magnetic beads 30 at the step.

  In the present embodiment, the first and second cleaning containers 210 and 220 are used. However, two cleaning liquid plugs may be provided in one cleaning container, and the first cleaning container 210 is magnetically connected. If the beads 30 are accommodated, the reduced diameter portion 123 may not be provided in the first cleaning container 210. Moreover, although the nucleic acid extraction device 6 has been described in the present embodiment, it may be a biological substance extraction container. The biological substance-extracting container has an adsorption container 100 or a first cleaning container 210 as a first container having a first flow path.

  Hereinafter, each container used for the nucleic acid extraction device 6 will be described. In addition, each container used for the nucleic acid extraction device 6 is the same as each container of the container assembly 1 shown in FIGS.

5-1. Adsorption Container The adsorption container 100 used for the nucleic acid extraction device 6 will be described with reference to FIGS. FIG. 12 is a longitudinal sectional view before assembling the syringe unit 120, the first cleaning container 210, and the second cleaning container 220 constituting the nucleic acid extraction device 6. 13 and 14 are schematic diagrams for explaining the operation of the nucleic acid extraction device 6 according to the embodiment. In FIGS. 13 and 14, the moving directions of the magnets 3 </ b> A and 3 </ b> B are indicated by arrows as up and down and front and rear. The movement of the magnetic beads 30 from the third flow path 2c to the second flow path 2b is basically the same as the movement of the magnetic beads 30 from the second flow path 2b to the first flow path 2a. Description is omitted.

  As shown in FIG. 12, the adsorption container 100 has a first flow path 2a. The adsorption container 100 is formed so that it can be joined to the first cleaning container 210.

In the adsorption container 100, the plunger part 130 is inserted into the syringe part 120, and the film F1 is attached to the upper end of the syringe part 120. The syringe part 120 has a suction insertion part 122 at one end of the first flow path 2a. The suction insertion portion 122 is substantially cylindrical and has an outer surface and an inner surface with a circular cross section.

  The syringe part 120 has a suction cover part 126 that is formed around the suction insertion part 122 and opens downward from the upper part of the outer surface. A film F <b> 2 is attached to the inner surface of the suction cover portion 126.

  The upper and lower openings of the adsorption container 100 are sealed with films F1 and F2 in a state where the air 11, the adsorbed liquid 10, and the first oil 20 are stored in this first flow path 2a in this order from the top. The adsorbing liquid 10 is a first liquid, and the first oil 20 is a fluid that is immiscible with the adsorbing liquid 10. Moreover, since the 1st flow path 2a is sealed by the front-end | tip part of the plunger part 130, the adsorption liquid 10 does not move. In the stationary state of the adsorption container 100, the adsorbed liquid 10 and the air 11 are not miscible at the interface but are free interfaces.

  The suction insertion part 122 has a first inner diameter changing part 123. The first inner diameter changing portion 123 can guide the movement of the magnetic beads 30. As shown in FIG. 13, the first inner diameter changing portion 123 has a truncated cone-shaped second shape that gradually decreases from the opening end 120 d toward the first inner surface 120 a that forms the narrow portion of the first flow path 2 a. It is formed by the inner surface 120c. The second inner surface 120c is an inclined surface having a straight vertical section, but may be curved as long as the movement of the magnetic beads 30 is not hindered, and has a partially curved portion and a straight portion. It may be.

5-2. First Cleaning Container The first cleaning container 210 will be described with reference to FIGS.

  As shown in FIG. 12, the 1st washing | cleaning container 210 has the 2nd flow path 2b. The first cleaning container 210 is a fluid that is immiscible with the first cleaning liquid 12 and the first cleaning liquid 12 in the second flow path 2b by sealing the upper and lower openings with films F3 and F4. The first and second oils 20 and 22 are sealed and stored. The first oil 20 and the second oil 22 sealed and stored in the first cleaning container 210 hold the first cleaning liquid 12 in a plug shape.

  The first cleaning container 210 has a first insertion part 212 at one end of the second flow path 2b and a first receiving part 214 at the other end. The 1st washing container 210 has the 1st cover part 216 formed in the circumference of the 1st insertion part 212, and film F4 is stuck on the inner side. The first receiving portion 214 is substantially cylindrical and has a fourth inner surface 210d having a circular cross section, and a film F3 is attached to the end thereof.

  The second flow path 2 b formed inside the first cleaning container 210 penetrates from the first insertion part 212 to the first receiving part 214. One end of the second flow path 2b has a second inner diameter changing portion 213b whose distance from the center of the second flow path 2b gradually increases. The center of the second flow path 2b is the center of the inner diameter of the second flow path 2b. The inner surface that forms the second flow path 2b includes a first inner surface 210a that forms a narrow portion in the second flow path 2b, a second inner surface 210b that forms a thick portion, and a fourth inner surface 210d that receives the suction insertion portion 122. And a third inner surface 210c having a truncated cone shape extending from the second inner surface 210b to the fourth inner surface 210d. The third inner surface 210c forms part of the second inner diameter changing portion 213b.

As shown in FIG. 13, the outer surface of the suction insertion portion 122 contacts the third inner surface 210c and the fourth inner surface 210d, and the end portion 120d contacts the middle of the third inner surface 210c. Therefore, the diameter of the flow path 2 is increased from the second inner surface 210b forming the wide portion of the flow path 2 to the third inner surface 210c of the second inner diameter changing portion 213b (the cross section S4 extends to the cross section S3), and the end 120d. From the first inner diameter changing portion 123, the second inner surface 120c reduces the diameter (the cross section S3 becomes narrower to the cross section S2) and smoothly leads to the first inner surface 120a that forms the narrow portion of the flow path 2. Therefore, when the magnetic beads 30 are moved from the first cleaning container 210 side, the movement is not hindered by the joint portion between the containers.

  By having the second inner diameter changing portion 213b like the first cleaning container 210, when the suction container 100 and the first cleaning container 210 are joined, the tip of the suction insertion portion 122 is slightly displaced in the vertical direction. However, it is possible to smoothly connect the second inner diameter changing portion 213b to the first inner diameter changing portion 123 without making a step. This is advantageous in terms of molding accuracy of the adsorption container 100 and the first cleaning container 210. Therefore, the second inner diameter changing portion 213b may not be provided as long as the end portion 120d of the adsorption container 100 has a processing accuracy that allows the end portion 120d to be always in contact with the end portion of the second inner surface 210b.

  As shown in FIG. 12, the 1st insertion part 212 is substantially cylindrical shape. In addition, the first insertion portion 212 has a third inner diameter changing portion 213a at an opening portion of the second flow path 2b. The distal end portion of the first insertion portion 212 a contacts the fourth inner diameter changing portion 223 b of the second receiving portion 224 of the second cleaning container 220. The third inner diameter changing portion 213a has the same structure as the first inner diameter changing portion 123, and the fourth inner diameter changing portion 223b has the same structure as the second inner diameter changing portion 213b, and thus the description thereof is omitted.

5-3. Second Cleaning Container As shown in FIG. 12, the second cleaning container 220 has a third flow path 2c. The second cleaning container 220 is a fluid that is immiscible with the second cleaning liquid 14 and the second cleaning liquid 14 in the third flow path 2c by sealing the upper and lower openings with the films F5 and F6. The second and third oils 22 and 24 and the magnetic beads 30 which are substance-bonding solid carriers are sealed and accommodated. The second oil 22 and the third oil 24 sealed and accommodated in the second cleaning container 220 hold the second cleaning liquid 14 in a plug shape.

  The second cleaning container 220 has a second insertion part 222 at one end of the third flow path 2c and a second receiving part 224 at the other end. The second cleaning container 220 has a second cover part 226 formed around the second insertion part 222, and a film F6 is attached to the inside of the second cover part 226. The second receiving portion 224 is substantially cylindrical and has an inner surface with a circular cross section, and a film F5 is stuck on the surface thereof.

  The third flow path 2 c formed inside the second cleaning container 220 penetrates from the second insertion part 222 to the second receiving part 224. The diameter of the third flow path 2 c is formed so as to gradually decrease from the second receiving portion 224 toward the second insertion portion 222.

  Since the second receiving unit 224 is the same as the first receiving unit 214 of the first cleaning container 210, description thereof is omitted. Accordingly, the second receiving portion 224 and the first insertion portion 212 are joined in the same manner as the first receiving portion 214 and the suction insertion portion 122.

  The second insertion portion 222 is substantially cylindrical and has an outer surface with a circular cross section. The second insertion portion 222 has no reduced diameter portion.

  The second cleaning container 220 stores the second oil 22, the second cleaning liquid 14, the third oil 24, the magnetic beads 30, and the third oil 24 in this order from the second receiving portion 224 side in the third flow path 2c. The second oil 22 and the third oil 24 sealed and accommodated in the second cleaning container 220 hold the second cleaning liquid 14 in a plug shape, and the third oil 24 holds the magnetic beads 30. Since the 2nd washing | cleaning liquid 14 does not contain a chaotropic substance as above-mentioned, if the 2nd washing | cleaning container 220 is the state sealed with the films F5 and F6, deterioration of the magnetic bead 30 by a chaotropic substance can be prevented.

  In the joining of the adsorption container 100 and the first cleaning container 210 and the joining of the first cleaning container 210 and the second cleaning container 220, the insertion portions 122 and 212 and the receiving portions 214 and 224 break through the films F2 to F5. Then, the suction insertion portion 122 is inserted into the first receiving portion 214, and the first insertion portion 212 is inserted into the second receiving portion 224. Therefore, each film F <b> 2 to F <b> 5 is broken so that the first flow path 2 a in the adsorption container 100 communicates with the third flow path 2 c in the second cleaning container 220.

  Since the magnetic beads 30 have to adsorb the target nucleic acid in the adsorption container 100, it is desirable to move the magnetic beads 30 to the adsorption container 100 as soon as each container is joined.

5-4. Description of Operation An operation for moving the magnetic beads 30 from the second flow path 2b to the first flow path 2a will be described with reference to FIGS.

  As shown in FIG. 13, the magnetic beads 30 are attracted to the magnet 3 </ b> B having a shorter distance among the magnets 3 </ b> A and 3 </ b> B, and therefore gather on the second inner surface 210 b in the forward direction of the second flow path 2 b. In this state, when the magnet 3B is moved upward (second direction D2 in FIG. 11), the magnetic beads 30 are also moved upward along the second inner surface 210b of the second flow path 2b (at the positions indicated by broken lines). Moving).

  As shown in FIG. 14, when the magnets 3A and 3B are further moved upward, the magnetic beads 30 move along the inner surfaces 210c and 120c of the second inner diameter changing portion 213b and the first inner diameter changing portion 123, It reaches the first inner surface 120a. If the magnets 3 </ b> A and 3 </ b> B are moved upward as they are, they can be moved into the adsorption liquid 10 of the adsorption container 100. Since the magnetic beads 30 move along the inner surface, if there is a step in the flow path 2, the step cannot be easily exceeded. In this way, the second inner diameter changing portion 213 b and the first inner diameter changing portion By having 123, the magnets 3A and 3B can be moved smoothly by simply moving upward.

  Thereafter, in the adsorption container 100, when the target nucleic acid is adsorbed to the magnetic beads 30, the magnets 3A and 3B are moved downward to move the magnetic beads 30 together with the target nucleic acid from the first flow path 2a to the second flow path 2b. And to the third flow path 2c. The downward movement of the magnetic beads 30 can be smoothly moved by simply moving the magnets 3A and 3B downward from the first inner diameter changing portion 123 to the second inner diameter changing portion 213b.

6). Nucleic Acid Extraction Device A nucleic acid extraction device 50A as a biological material extraction device will be described with reference to FIGS. FIG. 15 is a block diagram of a nucleic acid extraction apparatus 50A according to the embodiment. FIG. 16 is a side view of the nucleic acid extraction apparatus 50A according to the embodiment. The nucleic acid extraction apparatus 50 </ b> A performs a nucleic acid extraction process using the nucleic acid extraction device 6. In the following description, up and down and front and rear are defined as shown by arrows in FIG. That is, the vertical direction when the base 51 of the nucleic acid extraction apparatus 50A is installed horizontally is defined as “vertical direction”, and “upper” and “lower” are defined according to the direction of gravity. The direction perpendicular to the vertical direction and in which the magnets 3A and 3B swing with respect to the nucleic acid extraction device 6 is referred to as “front-rear direction”.

  As shown in FIG. 15, the nucleic acid extraction apparatus 50A includes a magnet moving mechanism 70 including a lifting motor 73B and a swinging motor 75A, and a controller 90A.

6-1. Controller The controller 90A is a control unit that controls the nucleic acid extraction apparatus 50A. The controller 90A includes, for example, a processor such as a CPU and a storage device such as a ROM and a RAM. Various programs and data are stored in the storage device. Further, the storage device provides an area for developing a program. Various processes are realized by the processor executing the program stored in the storage device.

  For example, the controller 90A controls the lifting motor 73B to move the magnets 3A and 3B in the vertical direction. The controller 90A controls the swing motor 75A to swing the magnets 3A and 3B in the front-rear direction. The elevating motor 73B and the swinging motor 75A are controlled by rotating a predetermined number of pulses set in advance from the initial position by pulse control. The nucleic acid extraction apparatus 50A may be provided with a position sensor for detecting the positions of the magnets 3A and 3B. In this case, the controller 90A is configured to move the lifting motor 73B and the swing motor according to the detection result of the position sensor. The motor 75A can be driven / stopped.

  As shown in FIG. 16, the nucleic acid extraction apparatus 50A includes a fixing unit 63 that fixes the nucleic acid extraction device 6 and a magnet moving mechanism 70 that moves the magnets 3A and 3B along the nucleic acid extraction device 6 fixed to the fixing unit 63. And having.

  The fixing part 63 is located at the lower end of the rotating body 61 and fixes the nucleic acid extraction device 6 to a predetermined position with respect to the rotating body 61. The rotator 61 can rotate in the direction of the arrow. For example, in a state where the rotator 61 is rotated by −30 degrees clockwise, the operator inserts the nucleic acid extraction device 6 into the fixing unit 63 and fixes it. . Then, after rotating the rotator 61 counterclockwise by +30 degrees and the nucleic acid extraction device 6 is in the initial state as shown in FIG. 16, the magnet moving mechanism 70 is operated.

6-2. Magnet moving mechanism The magnet moving mechanism 70 is a mechanism for moving the magnets 3A and 3B. The magnet moving mechanism 70 draws the magnetic beads 30 in the nucleic acid extraction device 6 to the magnets 3A and 3B and moves the magnetic beads 30 in the nucleic acid extraction device 6 by moving the magnets 3A and 3B. The magnet moving mechanism 70 includes a pair of magnets 3 </ b> A and 3 </ b> B, an elevating mechanism 73, and a swinging mechanism 75.

  The magnets 3A and 3B are members that attract the magnetic beads 30, and permanent magnets, electromagnets, and the like can be used. The pair of magnets 3A and 3B are substantially the same in the vertical direction, and are held by the arm 72 so as to face each other with the nucleic acid extraction device 6 sandwiched in the front-rear direction.

  The lifting mechanism 73 is a mechanism that moves the magnets 3A and 3B in the vertical direction. The elevating mechanism 73 includes a carriage 73A that moves in the vertical direction, and an elevating motor 73B. The carriage 73A is a member that is movable in the vertical direction, and is guided in the vertical direction by a carriage guide 73C provided on the side wall 53 that rises from the base 51 in the vertical direction. The lifting motor 73B is a power source that moves the carriage 73A in the vertical direction. The lifting motor 73B moves the carriage 73A to a predetermined position in the vertical direction in accordance with an instruction from the controller 90. The elevating motor 73B can move the carriage 73A in the vertical direction using pulleys 73E and 73F provided at the upper and lower ends of the side wall 53 and a belt 73D wound around them.

  The swing mechanism 75 is a mechanism that swings the pair of magnets 3A and 3B in the front-rear direction. When the pair of magnets 3A, 3B is swung in the front-rear direction, the distance between each magnet 3A, 3B and the nucleic acid extraction device 6 changes alternately. Since the magnetic beads 30 are attracted toward the magnets 3A and 3B that are closer to each other, the magnetic beads 30 in the nucleic acid extraction device 6 are moved in the front-rear direction by swinging the pair of magnets 3A, 3B in the front-rear direction.

  The swing mechanism 75 includes a swing motor 75A and a fixed plate 75C. The fixed plate 75C is attached to the carriage 73A and is movable in the vertical direction together with the carriage 73A. The fixing plate 75C fixes the swinging motor 75A. The power of the swing motor 75A is transmitted to the swing rotation shaft 75B via a gear (not shown), whereby the arm 72 holding the magnets 3A and 3B is centered around the swing rotation shaft 75B with respect to the carriage 73A. Rotate. The swing mechanism 75 swings the magnets 3A and 3B back and forth within a range where the magnets 3A and 3B and the nucleic acid extraction device 6 do not contact each other. If the magnets 3A and 3B can be moved in the front-rear direction, a horizontal movement mechanism or the like may be provided instead of the swing mechanism 75.

6-3. Nucleic acid extraction process
(A) assembling the nucleic acid extraction device 6 by joining the adsorption container 100, the first cleaning container 210, and the second cleaning container 220;
(B) fixing the nucleic acid extraction device 6 to the fixing unit 63 of the nucleic acid extraction apparatus 50A;
(C) introducing a sample containing nucleic acid into the adsorption container 100 in which the adsorbing liquid 10 is stored;
(D) rotating the rotator 61 to set the nucleic acid extraction device 6 to the initial position;
(E) moving the magnetic beads 30 from the second cleaning container 220 to the adsorption container 100;
(F) swinging the adsorption container 100 to adsorb the nucleic acid to the magnetic beads 30;
(G) a step of moving the magnetic beads 30 adsorbed with nucleic acids from the adsorption container 100 in the order of the first oil 20, the first cleaning liquid 12, the second oil 22, the second cleaning liquid 14, and the third oil 24; ,
including.

  Here, in the step (e), as described with reference to FIGS. 11 to 14, the magnets 3 </ b> A and 3 </ b> B are moved by the magnet moving mechanism 70, and the magnetic beads 30 disposed in the second cleaning container 220 are moved. It moves into the adsorption container 100 along the fourth inner diameter changing section 223b, the third inner diameter changing section 213a, the second inner diameter changing section 213b, and the first inner diameter changing section 123. In this way, the magnets 3A and 3B are moved by the magnet moving mechanism 70 and the magnetic beads 30 are moved along the inner surfaces 220a to 220c, 210a to 210c, 120c, and 120a of the flow path 2 so that the magnetic beads 30 can be The three flow paths 2c can move to the first flow path 2a.

Furthermore, when the nucleic acid extraction device 6 includes the third washing container 230 and the elution container 300 as described with reference to FIGS.
(G ′) a step of moving the magnetic beads 30 having the nucleic acid adsorbed to the elution container 300 through the third cleaning liquid 16 and the fourth oil 26;
(H) in the elution container 300, desorbing the nucleic acid from the magnetic beads 30 and eluting it into the eluate 32;
Can be included.

  After the target nucleic acid is adsorbed to the magnetic beads 30 moved to the adsorption container 100 in this way, the magnetic beads 30 are moved into the first and second washing containers 210 and 220 or the first to third washing containers 210 by the magnet moving mechanism 70. The target nucleic acid can be desorbed from the magnetic beads 30 by being moved along the flow path 2 in the elution container 300.about.230.

The present invention is not limited to the above-described embodiments, and various modifications can be made. For example, the present invention includes configurations that are substantially the same as the configurations described in the embodiments (for example, configurations that have the same functions, methods, and results, or configurations that have the same objects and effects). In the embodiment described above, the first container is an adsorption container and the second container is a cleaning container. However, the present invention is not limited to this, and the first container and the second container can be other containers. For example, the first container is the cleaning container 200.
In the case where the second container is the elution container 300, the magnetic beads 30 after the target nucleic acid is eluted can be obtained by adopting the enlarged diameter part and the reduced diameter part at the junction between the washing container 200 and the elution container 300. The elution container 300 can be pulled up to the cleaning container 200. In addition, the invention includes a configuration in which a non-essential part of the configuration described in the embodiment is replaced. In addition, the present invention includes a configuration that exhibits the same operational effects as the configuration described in the embodiment or a configuration that can achieve the same object. In addition, the invention includes a configuration in which a known technique is added to the configuration described in the embodiment.

DESCRIPTION OF SYMBOLS 1 ... Container assembly, 2 ... Flow path, 2a ... 1st flow path, 2b ... 2nd flow path, 2c ... 3rd flow path, 3 ... Magnet, 3A ... Magnet (rear), 3B ... Magnet (front), DESCRIPTION OF SYMBOLS 5 ... Nucleic acid purification device, 6 ... Nucleic acid extraction device, 10 ... Adsorption liquid, 11 ... Air, 12 ... 1st washing | cleaning liquid, 14 ... 2nd washing | cleaning liquid, 16 ... 3rd washing | cleaning liquid, 20 ... 1st oil, 22 ... 2nd oil 24 ... third oil, 26 ... fourth oil, 30 ... magnetic beads, 32 ... eluate, 34 ... reagent, 36 ... droplet, 50 ... PCR device, 50A ... nucleic acid extraction device, 51 ... base, 53 ... side wall 55 ... Fluorescence measuring device, 60 ... Rotation mechanism, 61 ... Rotating body, 63 ... Fixing part, 65 ... Heater, 66 ... Rotating motor, 70 ... Magnet moving mechanism, 72 ... Arm, 73 ... Elevating mechanism, 73A ... Carriage 73B ... Lifting motor, 73C ... Carriage guide, 73D ... 73E ... pulley, 73F ... pulley, 75 ... oscillation mechanism, 75A ... oscillation motor, 75B ... oscillation rotation shaft, 75C ... fixing plate, 80 ... pressing mechanism, 90 ... controller, 90A ... controller, 100 ... adsorption Container 110, Cap 112, Ventilation part 120, Syringe part 120 a First inner surface 120 c Second inner surface 120 d End part 122 Adsorption insertion part 123 First inner diameter changing part 126 Adsorption cover part, 130 ... Plunger part, 132 ... Bar-shaped part, 134 ... Tip part, 200 ... Cleaning container, 210 ... First cleaning container, 210a ... First inner surface, 210b ... Second inner surface, 210c ... Third inner surface, 210d ... 4th inner surface, 212 ... 1st insertion part, 213a ... 3rd internal diameter change part, 213b ... 2nd internal diameter change part, 214 ... 1st receiving part, 216 ... 1st cover 220, second cleaning container, 220a, first inner surface, 222, second insertion section, 223b, third diameter expansion section, 224, second receiving section, 226, second cover section, 230, third cleaning container. 232... Third insertion portion 234. Third receiving portion 236. Third cover portion 300... Elution container 302... Elution insertion portion 304 .. Elution receiving portion 400. Reaction accepting portion, 406 ... reservoir portion, F1-F6 ... film, D1 ... first direction, D2 ... second direction, S1-S4 ... cross section

Claims (9)

A first container having a first flow path, and a second container having a second flow path,
One end of the first flow path is inserted into one end of the second flow path so that the first flow path and the second flow path communicate with each other, and the first container to the second container A flow path for moving the biological material in the first direction toward the
The one end of the first flow path has a first inner diameter changing portion in which the inner diameter of the first flow path gradually decreases in a second direction opposite to the first direction. A bio-related substance extraction device that is characterized. A first container having a first flow path, and a second container having a second flow path,
One end of the first flow path is inserted into one end of the second flow path so that the first flow path and the second flow path communicate with each other, and the first container to the second container A flow path for moving the biological material in the first direction toward the
The one end portion of the first flow path is a finite value whose rate of change in inner diameter is not zero from the one end portion of the first flow path toward the second direction opposite to the first direction. A biological substance-extracting device, comprising: a first inner diameter changing portion having: In claim 1 or 2,
The living body related substance extraction device, wherein the one end portion of the second flow path has a second inner diameter changing portion whose distance from the center of the second flow path is gradually increased. In any one of Claims 1-3,
In the first flow path, a first liquid and a fluid immiscible with the first liquid are sealed and stored,
A biological substance-extracting device, wherein the second flow path contains a second liquid and a fluid that is immiscible with the second liquid in a sealed manner. In any one of Claims 1-4,
A biological substance-extracting device, characterized in that a substance-binding solid phase carrier is disposed downstream of the first inner diameter changing portion where the biological substance moves. In claim 4,
The first container is an adsorption container;
The second container is a cleaning container;
The first liquid is an adsorbent;
The bio-related substance extraction device, wherein the second liquid is a cleaning liquid. In any one of Claims 1-6,
The second container is a first cleaning container;
A third container having a third flow path and containing a third liquid, a fluid immiscible with the third liquid, and a substance-binding solid phase carrier in the third flow path;
The second container and the third container are joined to form the flow path for moving the biological material in the first direction;
One end of the second flow path is inserted into one end of the third flow path, and the second flow path and the third flow path communicate with each other.
The one end portion of the second flow path has a third inner diameter changing section in which the inner diameter of the second flow path gradually decreases in the second direction, and the bio-related substance extraction unit device. A fixing unit for fixing the biological material extraction device according to any one of claims 1 to 7,
A magnet moving mechanism for moving a magnet along the biological material extraction device fixed to the fixing unit;
Have
The magnet moving mechanism moves the magnet to move the substance-binding solid phase carrier disposed in the second container into the adsorption container along the reduced diameter portion. Related substance extraction equipment. A first container having a first flow path;
One end of the first flow path is inserted into an end of the second flow path of the second container so that the first flow path and the second flow path communicate with each other. A flow path for moving the biological material in the first direction toward the two containers is formed,
The one end has a first inner diameter changing portion in which an inner diameter of the first flow path gradually decreases in a second direction opposite to the first direction. Substance extraction container.